Pfizer (PFE) COVID Pill Paxlovid Gets CHMP Support in Europe

The CHMP supports the use of Pfizer’s (PFE) oral COVID-19 drug, Paxlovid, to treat high-risk patients even though it has not received conditional authorization from the European Commission.

Leave a comment

Your email address will not be published. Required fields are marked *